CD163 and breast carcinoma: Previous studies had confirmed that S100A7 expression could facilitate the infiltration of tumor-associated macrophages through multiple mechanisms in breast cancer, for example, it facilitated the infiltration of CD163-positive tumor-associated macrophages through activation of cPLA2 [33].